Article Text

Download PDFPDF
Letter
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis
  1. Guohong Han1,
  2. Xingshun Qi1,
  3. Wengang Guo1,
  4. Jing Niu1,
  5. Ming Bai1,
  6. Daiming Fan2
  1. 1Department of Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China
  2. 2State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China
  1. Correspondence to Professor Guohong Han, Department of Digestive Interventional Radiology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, No. 15 West Changle Road, Xi'an, 710032 China; guohhan{at}126.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the recent study by Luca et al demonstrating excellent short- and long-term outcomes of transjugular intrahepatic portosystemic shunt (TIPS) for the management of portal vein thrombosis (PVT) in patients with liver cirrhosis.1 More notably, the TIPS success rate can reach 100%. Additionally, the independent predictors for complete portal vein recanalisation have been proposed, including thrombosis of a single vein at inclusion, PVT severity of grade I (<25% of lumen occupancy), de novo diagnosis of PVT and absence of gastro-oesophageal varices. In spite of these important findings, several points of this study are worthy of further discussion.

First, even though this study was the largest case series consisting of 70 PVT-TIPS …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.